Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes [Yahoo! Finance]
Generation Bio Co. - Common stock (GBIO)
Company Research
Source: Yahoo! Finance
Financial Position : The company believes its current cash balance is sufficient to achieve key development milestones. Research and Development : Ongoing optimization of iqDNA for hemophilia A program and exploration of new therapeutic applications. Corporate Vision : GBIO aims to extend the reach of genetic medicine to more patients worldwide with its non-viral genetic medicine platforms. Warning! GuruFocus has detected 2 Warning Signs with GBIO. On March 6, 2024, Generation Bio Co ( NASDAQ:GBIO ) released its 8-K filing , detailing the company's business highlights and financial results for the fourth quarter and full year of 2023. GBIO, a biotechnology firm dedicated to developing genetic therapies for rare and prevalent diseases, has reported significant advancements in its proprietary platforms, which are poised to revolutionize the delivery of genetic medicines. Company Overview Generation Bio Co is at the forefront of genetic medicine, with a focus on creating gen
Show less
Read more
Impact Snapshot
Event Time:
GBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GBIO alerts
High impacting Generation Bio Co. - Common stock news events
Weekly update
A roundup of the hottest topics
GBIO
News
- Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingGlobeNewswire
- Generation Bio Co. (NASDAQ: GBIO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.MarketBeat
- Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- Generation Bio Co. (NASDAQ: GBIO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.MarketBeat
GBIO
Earnings
- 3/6/24 - Miss
GBIO
Sec Filings
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- 4/24/24 - Form DEF
- GBIO's page on the SEC website